NCT03674528View on ClinicalTrials.gov

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

May 4, 2018

Primary Completion Date

June 11, 2024

Study Completion Date

June 11, 2024

Conditions
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
Interventions
OTHER

Magnetic Resonance Elastography (MRE)

The MRE scan will several breath holds and will take approximately 30 minutes to complete.

DIAGNOSTIC_TEST

Liver biopsy

Subjects undergoing WLS will be asked to allow for liver biopsy samples to be collected during their surgical procedure. The collection of these samples will take approximately 5 minutes to complete.

Trial Locations (2)

53704

University of Wisconsin, Madison, Madison

92093

University of California, San Diego, La Jolla

Sponsors

Collaborators (2)

GE Healthcare
Pfizer
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

GE Healthcare

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Siemens Medical Solutions

INDUSTRY

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Wisconsin, Madison

OTHER